Skip to main content
. 2023 Dec 21;14:1300061. doi: 10.3389/fimmu.2023.1300061

Table 3.

Utility of HTS-TCR in skin: key points.

 T-cell clonality tests are now an essential component of the diagnostic toolkit for CTCL
 Immunosequencing precisely identifies and quantifies the genetic sequence of TCR CDR3 of malignant clones
 Increased sensitivity and specificity of HTS-TCR compared to PCR aids in diagnosis of early-stage MF
 HTS-TCR can provide TCF, a measure that has prognostic value
 HTS-TCR can be used to monitor the treatment response by tracking malignant T-cell clones in the skin and blood after treatment
 HTS-TCR can help distinguish between disease recurrence, treatment related cutaneous adverse events, and co-existing malignancies